CG Oncology (CGON) Institutional Ownership → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free CGON Stock Alerts $30.11 -0.86 (-2.78%) (As of 12:46 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)CurrentInstitutional OwnershipPercentage26.56%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$588.78MNumber ofInstitutional Sellers(last 12 months)0 Get CGON Insider Trade Alerts Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGON Institutional Buying and Selling by Quarter Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. CG Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024California State Teachers Retirement System2,341$103K0.0%N/A0.004% 5/16/2024 Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283% 5/16/2024 BVF Inc. IL1,884,191$82.72M2.3%N/A2.827% 5/16/2024 Blackstone Inc.25,000$1.10M0.0%N/A0.038% 5/15/2024 Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489% 5/15/2024 Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050% 5/14/2024 StemPoint Capital LP40,723$1.79M0.5%N/A0.061% 5/14/2024 Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191% 5/14/2024 American International Group Inc.306,226$13.44M0.0%N/A0.460% 5/13/2024 Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003% 5/10/2024 Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339% 5/7/2024 TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336% 5/1/2024 Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028% 5/1/2024 BNP Paribas Financial Markets11,198$492K0.0%N/A0.017% (Data available from 1/1/2016 forward) CGON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGON shares? During the previous two years, 14 institutional investors and hedge funds held shares of CG Oncology. The most heavily invested institutionals were Decheng Capital LLC ($239.64M), Vanguard Group Inc. ($97.68M), BVF Inc. IL ($82.72M), Janus Henderson Group PLC ($66.76M), Price T Rowe Associates Inc. MD ($43.56M), Avoro Capital Advisors LLC ($30.73M), and American International Group Inc. ($13.44M).Learn more on CGON's institutional investors. What percentage of CG Oncology stock is owned by institutional investors? 26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings. Which institutional investors have been buying CG Oncology stock? Of the 14 institutional investors that purchased CG Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), BVF Inc. IL ($1.88M), Janus Henderson Group PLC ($1.52M), Price T Rowe Associates Inc. MD ($992.12K), Avoro Capital Advisors LLC ($700K), and American International Group Inc. ($306.23K). How much institutional buying is happening at CG Oncology? Institutional investors have bought a total of 13,411,804 shares in the last 24 months. This purchase volume represents approximately $588.78M in transactions. Related Companies: Fusion Pharmaceuticals Institutional Ownership Ginkgo Bioworks Institutional Ownership Novavax Institutional Ownership Inhibrx Institutional Ownership Beam Therapeutics Institutional Ownership Sana Biotechnology Institutional Ownership ADMA Biologics Institutional Ownership Neumora Therapeutics Institutional Ownership Kymera Therapeutics Institutional Ownership Tarsus Pharmaceuticals Institutional Ownership This page (NASDAQ:CGON) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsObama’s Forever Term [exposed]Porter & CompanyDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
